Lonnie Moulder

Lonnie Moulder joined the Board in January 2020. Mr. Moulder is General Partner of Tellus BioVentures, LLC, a life science investment fund he founded in 2019. Previously Mr. Moulder was the co-founder, Chief Executive Officer and a member of the board of directors of TESARO, Inc., a public oncology-focused biopharmaceutical company that was acquired by GlaxoSmithKline plc. Previously Mr. Moulder served as Vice Chairman of the board of directors, President and Chief Executive Officer of Abraxis BioScience, Inc., a biotechnology company. Before that, Mr. Moulder served as Vice Chairman of Eisai Corporation of North America, a pharmaceutical company and wholly owned subsidiary of Eisai Co., Ltd., following Eisai Co., Ltd.’s acquisition of MGI PHARMA, Inc. Mr. Moulder served as President and Chief Executive Officer and as a member of the board of directors of MGI PHARMA, Inc.

Mr. Moulder is a Trustee of Temple University and serves as a board director for several public and privately held biotechnology companies. Mr. Moulder earned a B.S. in pharmacy from Temple University and a M.B.A. from the University of Chicago.